Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMR Surgical Launches Robotic System To Rival Intuitive’s Da Vinci

Executive Summary

UK-based CMR Surgical has debuted its new portable robotic system Versius. "Inspired by the human arm,” it is expected to assist in surgeries on European patients beginning next year. Versius is set to rival Intuitive Surgical’s da Vinci robot systems, the current market leader in robotic surgery.

You may also be interested in...



Exec Chat: Rapid Expansion For CMR Surgical As It Launches Robotic System In More Countries

Per Vegard Nerseth, CEO of private surgical robotics company CMR Surgical, spoke to Medtech Insight about the UK firm's plans to democratize robot-assisted surgery.

CMR Surgical Encouraged By First In-Human Series With Versius Robot

There have been no adverse events reported from the first 30 laparoscopic surgeries performed with CMR Surgical's robotic platform Versius in a hospital in India.

UK Into 2019: Health-Tech Adoption Not Far From The 'Tipping Point'

The UK's future economic relationship with the EU consumed more than its fair share of headlines in 2018. But within UK health care, at ground level, Brexit was often missing entirely from main conference agendas, as stakeholders sought to both maximize current operating conditions and prepare for future health-care architectures and evolving innovation systems. That was the case at Medtech Futures, in Cambridge, UK, this fall.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT123233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel